Evidence map›Paper›PMID 38672631›Full record

ReviewCancers2024

Prostate Tissue Microbiome in Patients with Prostate Cancer: A Systematic Review.

Daniela F Ward Grados, Onuralp Ergun, Carly D Miller, Petr Gaburak, Nana A Frimpong, Oluwatobi Shittu, Christopher A Warlick

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Microbial dysbiosis and inferred functional profiling reveals the potential role ofFrontiers in cellular and infection microbiology · 2026
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Daniela F Ward GradosDepartment of Urology, University of Minnesota, Minneapolis, MN 55455, USA.
Onuralp ErgunDepartment of Urology, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0001-6433-4534
Carly D MillerDepartment of Urology, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0009-0008-7609-0782
Petr GaburakDepartment of Urology, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0003-0539-3010
Nana A FrimpongDepartment of Urology, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0002-4846-5638
Oluwatobi ShittuDepartment of Urology, University of Minnesota, Minneapolis, MN 55455, USA.
Christopher A WarlickDepartment of Urology, University of Minnesota, Minneapolis, MN 55455, USA.
University of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some researchers have speculated that the prostatic microbiome is involved in the development of prostate cancer (PCa) but there is no consensus on certain microbiota in the prostatic tissue of PCa vs. healthy controls. This systematic review aims to investigate and compare the microbiome of PCa and healthy tissue to determine the microbial association with the pathogenesis of PCa. We searched MEDLINE, Embase, and Scopus databases. Articles were screened by two independent and blinded reviewers. Literature that compared the prostatic tissue microbiome of patients with PCa with benign controls was included. We found that PCa may be associated with increased

Indexed as

Cutibacteriummicrobiotaprostate cancerprostate microbiome

Identifiers

PMID38672631
PMCPMC11048594
OpenAlexW4394914346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.